Bupropion Prices

Bupropion Prices June 2023

In the second quarter of 2023, the price of the bupropion in the United States reached 72900 USD/MT by June. Similarly, in China, the bupropion prices hit 73300 USD/MT in the same month. Germany also saw bupropion prices reaching 77500 USD/MT during Q2 2023.

Bupropion Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Bupropion Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of bupropion pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of bupropion at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of bupropion price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing bupropion price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Bupropion Market Analysis

The global bupropion market size reached US$ 1.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 2.4 Billion, at a projected CAGR of 5.60% during 2023-2032.

• The increasing awareness and diagnosis of mental health conditions, including major depressive disorders and seasonal affective disorders, are driving the demand for effective treatment such as bupropion. According to the World Health Organization (WHO), an estimated 3.8% of the population experience depression, including 5% of adults (4% among men and 6% among women), and 5.7% of adults older than 60 years. Approximately 280,000,000 people in the world have depression. Depression is about 50% more common among women than among men. Worldwide, more than 10% of pregnant women and women who have just given birth experience depression.
• According to industry reports, approximately 5% of the US population experiences seasonal depression in any given year. Four out of five people with seasonal depression are women. The average age of onset is between 20 and 30 years old.
• The market for bupropion is driven by its effectiveness in helping smoking cessation as a public health initiative and individual efforts to quit smoking, which is boosting its demand. According to the data from the American Lung Association, smoking-related diseases claim more than 4,80,000 lives in the US each year. Smoking costs the US at least $289 billion each year, including at least $151 billion in lost productivity and $130 billion in direct healthcare expenditures. According to the report by CDC, nearly 70% of adults who smoke say they want to quit. Over 50% of adults who smoke try to quit each year. Three in five adults who ever smoked cigarettes have quit.
• The availability of a generic version of bupropion is making it more affordable and accessible, which is increasing its demand. According to the FDA, it is estimated that 91% of all prescriptions in the United States are filled as generic drugs, with more than 32,000 generic drugs approved by the FDA to date. For instance, a recent FDA study showed the savings accrued during the first year after approval for new generic drugs approved in 2018, 2019, and 2020 to be approximately $53.3 billion. This means tens of billions of dollars were saved each of those years, economy-wide, from new generic approvals.

Bupropion News

The report covers the latest developments, updates, and trends impacting the global bupropion market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in bupropion production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the bupropion price trend.

Latest developments in the bupropion industry:

• In February 2022, Drug Granules India received approval from the US health regulator to market Bupropion hydrochloride extended-release tablets, and antidepressant medication, in the American market.
• In August 2022, the Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy.

Product Description

Bupropion refers to an atypical antidepressant medication majorly utilized to treat major depressive disorder (MDD) and seasonal affective disorder (SAD). In addition to this, this medication is also prescribed to help in smoking cessation.

Unlike other antidepressants, bupropion does not fit neatly into the categories of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors. Instead, it majorly inhibits the reuptake of norepinephrine and dopamine, increasing their levels in the brain. This unique mechanism of action makes bupropion useful for patients who do not respond well to traditional antidepressants.

Bupropion is marketed under different brand names such as Zyban and Wellbutrin. In line with this, it is generally well-tolerated, though, side effects include dry mouth, headaches, and insomnia. Bupropion’s lower risk of sexual side effects compared to SSRIs adds to its appeal.

Regional Coverage

The report provides a detailed analysis of the bupropion market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the bupropion price trend.

Global Bupropion Price

The report offers a holistic view of the global bupropion pricing trends in the form of bupropion price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of bupropion but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed bupropion demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Bupropion Price

European bupropion prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed bupropion price information for a comprehensive list of countries.

North America Bupropion Price

The analysis of bupropion prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific bupropion historical data within the United States and Canada can also be provided.

Middle East and Africa Bupropion Price

The report explores the bupropion pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on bupropion prices for countries can also be provided.

Asia Pacific Bupropion Price

The bupropion pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This bupropion price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Bupropion Price

The analysis of bupropion prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of bupropion pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting bupropion price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The bupropion price charts ensure our clients remain at the forefront of the industry.